{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:05:36Z","timestamp":1780567536516,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1D1A1B07040656"],"award-info":[{"award-number":["NRF-2018R1D1A1B07040656"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cellimm.2021.104394","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T11:53:57Z","timestamp":1623153237000},"page":"104394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["B16 melanomas evade antitumor immunity by the loss of epitope presentation and the acquisition of tumor resistance to granzyme B"],"prefix":"10.1016","volume":"367","author":[{"given":"Jaeyeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Im","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2021.104394_b0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/sonc.2002.35237","article-title":"Systemic chemotherapy for the treatment of metastatic melanoma","volume":"29","author":"Li","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.cellimm.2021.104394_b0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/sonc.2002.35238","article-title":"Metastatic melanoma: chemotherapy","volume":"29","author":"Bajetta","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.cellimm.2021.104394_b0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2021.104394_b0020","first-page":"9","article-title":"Cancer statistics","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellimm.2021.104394_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-092012-112807","article-title":"Immune modulation in cancer with antibodies","volume":"65","author":"Page","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cellimm.2021.104394_b0030","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.155.4.2240","article-title":"IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response","volume":"155","author":"Kim","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104394_b0035","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood.V93.5.1634","article-title":"Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells","volume":"93","author":"Steinbrink","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2021.104394_b0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2407-9-231","article-title":"Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer","volume":"9","author":"Mansfield","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellimm.2021.104394_b0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2, 3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2021.104394_b0050","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7\u2013H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2021.104394_b0055","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/0008-5472.CAN-09-3109","article-title":"CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104394_b0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.1998.tb01574.x","article-title":"Ecto-enzyme and signaling functions of lymphocyte CD73","volume":"161","author":"Resta","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2021.104394_b0065","first-page":"527","article-title":"Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells","volume":"32","author":"Hoskin","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellimm.2021.104394_b0070","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00432-008-0393-3","article-title":"Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival","volume":"134","author":"Xu","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cellimm.2021.104394_b0075","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1172\/JCI17656","article-title":"Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes","volume":"111","author":"Bai","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2021.104394_b0080","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.canlet.2014.10.019","article-title":"A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model","volume":"356","author":"Ahn","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellimm.2021.104394_b0085","first-page":"215","article-title":"Persistence of immunogenic pulmonary metastases in the presence of protective anti-melanoma immunity","volume":"61","author":"Douawho","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104394_b0090","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1080\/21645515.2015.1016669","article-title":"MC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer model","volume":"11","author":"Lee","year":"2015","journal-title":"Human Vaccines & Immunother."},{"key":"10.1016\/j.cellimm.2021.104394_b0095","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1038\/s41598-019-39557-9","article-title":"Regulation of the translation activity of antigen-specific mRNA is responsible for antigen loss and tumor immune escape in a HER2-expressing tumor model","volume":"9","author":"Han","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2021.104394_b0100","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1158\/1078-0432.CCR-14-0879","article-title":"MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro","volume":"20","author":"Angell","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104394_b0105","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1158\/0008-5472.CAN-17-2325","article-title":"Targeting cyclin D-CDK4\/6 sensitizes immune-refractory cancer by blocking the SCP3-NANOG axis","volume":"78","author":"Oh","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104394_b0110","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00262-012-1214-8","article-title":"Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2180-188-specific CD8+ CTLs in a perforin\/granzyme-mediated and IFN-g-dependent manner: application of Trp2180-188 peptides","volume":"61","author":"Sin","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2021.104394_b0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.canlet.2012.11.045","article-title":"Combined stimulation of TLR9 and 4\u20131BB augments Trp2 peptide vaccine-mediated melanoma rejection by increasing Ag-specific CTLs and their infiltration into tumor sites","volume":"330","author":"Sin","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellimm.2021.104394_b0120","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1089\/dna.2011.1266","article-title":"Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control","volume":"30","author":"Lee","year":"2011","journal-title":"DNA & Cell Biol."},{"key":"10.1016\/j.cellimm.2021.104394_b0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-213X-8-32","article-title":"The receptor for granulocyte-colony stimulating factor (G-CSF) is expressed in radial glia during development of the nervous system","volume":"8","author":"Kirsch","year":"2008","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.cellimm.2021.104394_b0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/mol.52.1.30","article-title":"Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"52","author":"Lai","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cellimm.2021.104394_b0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/intimm\/dxh200","article-title":"The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infection","volume":"17","author":"Peng","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cellimm.2021.104394_b0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1095\/biolreprod59.1.93","article-title":"Species-specific detection of growth factor gene expression in developing murine prostatic tissue","volume":"59","author":"Haughney","year":"1998","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cellimm.2021.104394_b0145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1095\/biolreprod.103.019232","article-title":"Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient mice","volume":"70","author":"Basciani","year":"2004","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cellimm.2021.104394_b0150","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1095\/biolreprod.102.013581","article-title":"Expression of vascular endothelial growth factor receptors during male germ cell differentiation in the mouse","volume":"69","author":"Nalbandian","year":"2003","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cellimm.2021.104394_b0155","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1038\/sj.onc.1204086","article-title":"STAT proteins: novel molecular targets for cancer drug discovery","volume":"19","author":"Turkson","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cellimm.2021.104394_b0160","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1038\/sj.onc.1208469","article-title":"Stat3 regulates genes common to both wound healing and cancer","volume":"24","author":"Dauer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cellimm.2021.104394_b0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.advenzreg.2006.01.004","article-title":"Roles of the RAF\/MEK\/ERK and PI3K\/PTEN\/AKT pathways in malignant transformation and drug resistance","volume":"46","author":"McCubrey","year":"2006","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.cellimm.2021.104394_b0170","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2174\/1389450115666141120104146","article-title":"The role of STAT3 signaling in mediating tumor resistance to cancer therapy","volume":"15","author":"Tan","year":"2014","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.cellimm.2021.104394_b0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"STAT3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2021.104394_b0180","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/cancers6020926","article-title":"Transcription factor STAT3 as a novel molecular target for cancer prevention","volume":"6","author":"Xiong","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cellimm.2021.104394_b0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.26307","article-title":"The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models","volume":"131","author":"Hatiboglu","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellimm.2021.104394_b0190","first-page":"1270","article-title":"Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice","volume":"63","author":"Blaskovich","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104394_b0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00001813-200507000-00002","article-title":"Targeting Stat3 in cancer therapy","volume":"16","author":"Jing","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.cellimm.2021.104394_b0200","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1074-7613(00)80501-4","article-title":"Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis","volume":"5","author":"Fukada","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2021.104394_b0205","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","article-title":"Stat3 target genes relevant to human cancers","volume":"6","author":"Carpenter","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.cellimm.2021.104394_b0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1034\/j.1600-065X.2003.00044.x","article-title":"a natural born killer","volume":"193","author":"Lord","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2021.104394_b0215","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/mt.2009.32","article-title":"Adoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin\/granzyme-mediated pathway","volume":"17","author":"Sin","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellimm.2021.104394_b0220","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1074-7613(00)80213-7","article-title":"DFF45\/ICAD can be directly processed by granzyme B during the induction of apoptosis","volume":"12","author":"Thomas","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2021.104394_b0225","doi-asserted-by":"crossref","first-page":"11515","DOI":"10.1073\/pnas.201398198","article-title":"Blockade of the granzyme B\/perforin pathway through overexpression of the serine protease inhibitor PI-9\/SPI-6 constitutes a mechanism for immune escape by tumors","volume":"98","author":"Medema","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cellimm.2021.104394_b0230","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imlet.2013.04.004","article-title":"An emerging role for serine protease inhibitors in T lymphocyte immunity and beyond","volume":"152","author":"Ashton-Rickardt","year":"2013","journal-title":"Immunol. lett."},{"key":"10.1016\/j.cellimm.2021.104394_b0235","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1002\/eji.1830271250","article-title":"Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis","volume":"27","author":"Medema","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104394_b0240","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1074\/jbc.274.3.1541","article-title":"The role of c-FLIP in modulation of CD95-induced apoptosis","volume":"274","author":"Scaffidi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2021.104394_b0245","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1038\/onc.2009.47","article-title":"Bid: a Bax-like BH3 protein","volume":"27","author":"Billen","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cellimm.2021.104394_b0250","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1189\/jlb.71.6.907","article-title":"Immune escape of tumors: apoptosis resistance and tumor counterattack","volume":"71","author":"Igney","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2021.104394_b0255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","article-title":"Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2021.104394_b0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"X., Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellimm.2021.104394_b0265","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/0008-5472.CAN-10-1296","article-title":"Molecular mechanism of MART-1+\/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction","volume":"71","author":"Jazirehi","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2021.104394_b0270","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccell.2016.02.004","article-title":"Facilitating T cell infiltration in tumor microenvironment overcomes resistance to PD-L1 blockade","volume":"29","author":"Tang","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellimm.2021.104394_b0275","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1080\/21645515.2020.1866951","article-title":"B16 melanoma control by anti-PD-L1 requires CD8+ T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines","volume":"17","author":"Ji","year":"2021","journal-title":"Human Vaccines & Immunother"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874921001131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874921001131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:06:06Z","timestamp":1757804766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874921001131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":55,"alternative-id":["S0008874921001131"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104394","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B16 melanomas evade antitumor immunity by the loss of epitope presentation and the acquisition of tumor resistance to granzyme B","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104394"}}